Healthcare company, CardiacSense, will exhibit the industry’s first Medical Watch for long-term continuous and comfortable monitoring of heart arrhythmia.
The device is non-invasive and can be worn like a regular watch. Features include ECG monitoring, PhotoPlethysmoGram (PPG), proprietary sensors and algorithms. The monitoring technology claims to be able to detect heart arrhythmias which can lead to stroke or cardiac arrest. The watch is designed to simplify long-term and real-time monitoring for in-hospital and ambulatory patients, and as a result, it is hoped that the device could reduce healthcare costs.
CardiacSense has received ISO 13485:2016 certification for its quality management system from BSI UK and the device is in the advanced stages of FDA and CE certification.
The medical device will be introduced by Eldad Shemesh, CEO of CardiacSense in hall 16 on stand M25 at 15:00 on day one of Medica. Medica runs from 18th to 21st November.